Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 34.60B | 36.98B | 34.87B | 29.61B | 26.93B |
Gross Profit | 17.66B | 19.50B | 17.90B | 13.11B | 12.98B |
EBITDA | 5.21B | 6.69B | 5.72B | 1.62B | 2.59B |
Net Income | 2.57B | 3.64B | 5.30B | -1.78B | 122.00M |
Balance Sheet | |||||
Total Assets | 53.17B | 51.34B | 51.16B | 45.40B | 50.80B |
Cash, Cash Equivalents and Short-Term Investments | 21.65B | 20.13B | 20.40B | 19.48B | 18.79B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 6.39B | 8.40B | 11.37B | 8.78B | 9.96B |
Stockholders Equity | 46.78B | 42.94B | 39.79B | 36.62B | 40.83B |
Cash Flow | |||||
Free Cash Flow | 3.36B | 1.54B | 4.40B | 982.00M | -2.05B |
Operating Cash Flow | 4.61B | 3.73B | 5.51B | 3.07B | -52.00M |
Investing Cash Flow | -2.02B | -2.47B | -911.00M | -1.36B | -1.36B |
Financing Cash Flow | -1.17B | -1.13B | -3.47B | -1.12B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | ¥49.09B | 6.10 | 4.32% | -10.56% | -33.64% | ||
74 Outperform | ¥604.89B | 11.21 | 19.86% | 3.63% | -8.81% | 14.09% | |
69 Neutral | ¥28.10B | 6.72 | 2.53% | 19.63% | 23.87% | ||
68 Neutral | ¥22.19B | 8.64 | 5.18% | 0.55% | -24.89% | ||
67 Neutral | ¥263.01B | 13.51 | 6.45% | 2.58% | 5.16% | -13.18% | |
60 Neutral | ¥7.24B | 29.41 | 3.73% | -5.98% | -53.43% | ||
48 Neutral | $75.55B | ― | -7.04% | 3.09% | -33.01% | -191.81% |